Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Plasticell Announces CombiCult Patents

Published: Monday, November 18, 2013
Last Updated: Monday, November 18, 2013
Bookmark and Share
Additional family of CombiCult® patents granted in USA, Europe, Australia and Singapore.

Plasticell has announced that a further family of patents, offering additional protection of its proprietary cell culture technology, Combinatorial Cell Culture™ (CombiCult®), have been granted by the US Patent Office, European Patent Office, Australian Patent Office and Intellectual Property Office of Singapore.

The newly granted patents cover the use of nanomaterial tags to track the cell culture history of cells grown on beads and exemplify use of the method to deduce optimal culture conditions for the differentiation of stem cells. ‘These patents provide a secondary layer of coverage for Plasticell’s platform technology and extend the lifespan of patent protection,’ said Dr Yen Choo, founder and Executive Chairman of Plasticell and inventor of the methods.

Combinatorial Cell Culture™ forms the basis of the company’s CombiCult® system for high throughput screening of stem cell differentiation protocols. CombiCult® allows researchers to rapidly identify and/or optimise novel protocols which are highly efficient and/or cost-effective, free of undesirable media components such as serum, and to replace growth factors with small molecules.

Plasticell forms collaborations with industry partners to use CombiCult® in the production of rare cell types for research or therapy applications.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Plasticell, CellSpring Collaborate
Collaboration aims to validate osteogenic cell therapy and 3D cell culture models for high performance drug screening.
Monday, September 19, 2016
Plasticell, NUI Galway Collaborate
Plasticell has announced the signing of a collaboration agreement with the National University of Ireland, Galway focused on methods of eradicating cancer stem cells.
Tuesday, August 02, 2016
Plasticell and Pierre Fabre Laboratories Sign a Partnership
Company has announced collaboration to identify natural stimulants of brown fat for treatment and prevention of obesity and diabetes.
Wednesday, February 24, 2016
Plasticell and Veritas Announce an Exclusive Distribution Agreement in Japan
Veritas engaged as exclusive distributor for Plasticell’s services and products, including CombiCult®.
Monday, June 18, 2012
Plasticell Wins Further Funding for Stem Cell Manufacturing Project
Technology Strategy Board will provide a grant of approximately £750k towards a £1.5m project.
Wednesday, December 14, 2011
Plasticell Signs Stem Cell Research Collaboration with UCB
Plasticell will screen UCB’s drug compound libraries using CombiCult™ technology to discover new cell signaling pathways involved in stem cell biology.
Tuesday, November 09, 2010
Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Protein-Based “Cancer Signature” Uncovered
Researchers investigated the expression of ribosomal proteins in human tissues and discovered a cancer type specific signature which could be used to predict the progression of the disease.
Ribosome Recycling as a Drug Target
Researchers explain mechanism that recycles bacterial ribosomes stalled on messenger RNAs that lack termination codons.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Toxoplasma’s Balancing Act Explained
Parasite’s method of rewiring our immune response leads to novel tool for drug tests.
Cancer Signaling Pathway Illuminating Way To Therapy
Researchers refine a pro-growth signalling pathway, common to cancers, that can kill cancer cells while leaving healthy cells unharmed.
Breast Cancer Cells Starve for Cystine
Depriving triple negative breast cancer, a treatment-resistant form of breast cancer, of cystine results in cancer cell death.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!